Hepatitis C Challenges

The World Health Organization is actively working to improve access to hepatitis C screening and treatment, but challenges remain due to the high costs of diagnostic tools and medications. Developing a vaccine is complicated by the virus's rapid mutation and variability, making it difficult to generate a strong immune response. While blood products are now much safer in many regions, the risk of hepatitis C infection still exists in places with less rigorous testing.